CDC Escalates Ebola Response After WHO Emergency Declaration
The CDC has expanded its Ebola response after the WHO declared an international public health emergency, deploying mo...
Articles — Page 72
Why This Fund Just Made a $55 Million Bet on Dianthus
A prominent fund has poured roughly $55 million into Dianthus as the stock climbs 350%. This article breaks down what...
Alumis Stock Soared 400%: Cormorant Buys Another $8M
A sharp rise in Alumis shares coincides with a fresh stake from Cormorant Asset Management. This article breaks down ...
Ares Capital's Yield Just Survived a Difficult Quarter
Ares Capital has long dazzled income investors with a high dividend yield. After a challenging quarter, the question ...
This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Maze Therapeutics Stock Still Climbing After March Tumble
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Already Pinpoint Tripled Stake: GDS Move Signals Confidence
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
Investors React: With Down 29%, First Beijing Buys 13M Shares
When a top investor steps up after a steep drop, it signals conviction. This deep dive looks at why First Beijing bou...
China Tech Fund Opens a Biotech Position — What It Signals
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...